Metabolomic biomarkers in blood samples identify cancers in a mixed population of patients with nonspecific symptoms
<strong>Purpose:</strong> Early diagnosis of cancer is critical for improving patient outcomes, but cancers may be hard to diagnose if patients present with nonspecific signs and symptoms. We have previously shown that nuclear magnetic resonance (NMR) metabolomics analysis can detect can...
المؤلفون الرئيسيون: | Larkin, JR, Anthony, S, Johanssen, VA, Yeo, T, Sealey, M, Yates, AG, Smith, CF, Claridge, TDW, Nicholson, BD, Moreland, J-A, Gleeson, F, Sibson, NR, Anthony, DC, Probert, F |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
American Association for Cancer Research
2022
|
مواد مشابهة
-
Early diagnosis of brain metastases through biofluid metabolomics
حسب: Larkin, JR, وآخرون
منشور في: (2017) -
Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
حسب: Yeo, T, وآخرون
منشور في: (2019) -
Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
حسب: Probert, F, وآخرون
منشور في: (2021) -
A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application
حسب: Yeo, T, وآخرون
منشور في: (2020) -
Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
حسب: Yeo, T, وآخرون
منشور في: (2022)